Haplotypes | Number (%) | EGF-1 | EGF-2 | EGF-3 |
---|
27 | 87 | 97 | 100 | 130 | 131 |
---|
Sal-I | – | D | Q | E | T | I | Q |
pv01* | | | | Q | | T | |
H1 | 82 (25.3) | | | | | T | |
H2 | 1 (0.3) | N | | | | T | |
H3 | 46 (14.2) | | | Q | | T | |
H4 | 2 (0.6) | | | | S | T | |
H5 | 176 (54.3) | | | | | T | K |
H6 | 10 (3.1) | | | Q | | T | K |
H7 | 6 (1.9) | | L | Q | | T | K |
H8 | 1 (0.3) | N | | Q | | T | K |
Total | 324 (100) | – | – | – | – | – | – |
- EGF, epidermal growth factor-like domain. Dot (•) indicates identical amino acid residues compared to the Sal-I strain. *The pv01 strain from Indonesia was used as another compared sequence, which had the same variation 130T as the isolates from China. Bold letters indicate amino acid variation compared to the Sal-I strain